Availability of Guidelines

For each clinical practice guideline developed under the sponsorship of the Agency for Health Care Policy and Research (AHCPR), several versions are produced to meet different information needs.

The Guideline Report contains technical and supporting materials used in developing the guideline.

The Clinical Practice Guideline and the Quick Reference Guide for Clinicians are companion documents for use as desk-top references for clinical decisionmaking in day-to-day care of patients. Recommendations, algorithms or flow charts, tables and figures, and pertinent references are included.

A Patient's Guide, available in English and Spanish, is an informational booklet for the general public to increase consumer knowledge and involvement in health care decision making.

Guideline information also will be available for on-line retrieval through the National Library of Medicine, the National Technical Information Service, and some computer-based information systems of professional associations, nonprofit organizations, and commercial enterprises.

To order guideline products or to obtain further information on their availability, call the AHCPR Clearinghouse toll-free at (800) 358-9295; from outside the United States only, call (301) 495-3453; or write to: AHCPR Clearinghouse, P.O. Box 8547, Silver Spring, MD 20907.

[Tables]

Table 9: Summary of drugs commonly used in the emergency department to treat patients with symptoms suggestive of unstable angina

Table 10. Noninvasive studies in patients with unstable angina reporting at least 10 cardiac events (cardiac death or myocardial infarction) during followup

[Figures]

Figure 1: Outcomes of 21,761 medically treated patients at Duke University Medical Center, 1985-1992, grouped by ischemic heart disease diagnosis on admission

Availability of Guidelines

[Tables]

Table 1. Three principal presentations of unstable angina

Table 2. Grading of angina pectoris by the Canadian Cardiovascular Society classification system

Table 3. Definition of unstable angina care environments

Table 4. Grading of evidence

Table 5. Reported mortality of unstable angina

Table 6. ECG findings useful for establishing the likelihood of coronary artery disease

Table 7. Likelihood of significant coronary artery disease in patients with symptoms suggesting unstable angina

Table 8. Short-term risk of death or nonfatal myocardial infarction in patients with unstable angina

Table 9: Summary of drugs commonly used in the emergency department to treat patients with symptoms suggestive of unstable angina

Table 10. Noninvasive studies in patients with unstable angina reporting at least 10 cardiac events (cardiac death or myocardial infarction) during followup

[Figures]

Figure 1: Outcomes of 21,761 medically treated patients at Duke University Medical Center, 1985-1992, grouped by ischemic heart disease diagnosis on admission

Figure 2: Outcomes of medically treated patients with unstable angina

Figure 3: Entry of patients into the unstable angina guideline

Figure 4: Influence of thrombolysis on myocardial infarction in patients presenting with unstable angina

Figure 5: Relative risk of death or myocardial infarction in unstable angina patients treated with aspirin vs. placebo

Figure 6: Patient flow: Outpatient care

Figure 7: Patient flow: Intensive medical management

Figure 8: Patient flow: Progression to nonintensive medical management

Figure 9: Patient flow: Noninvasive testing

Figure 10: Noninvasive testing for risk stratification in patients with unstable angina

Figure 11: Nomogram of the prognostic relations embodied in the treadmill score

Figure 12: Patient flow: Cardiac catheterization and myocardial revascularization

Figure 13: Patient flow: Hospital discharge and postdischarge care